PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LH vs. CAH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


LHCAH
YTD Return-11.11%2.68%
1Y Return3.44%27.88%
3Y Return (Ann)-3.32%23.09%
5Y Return (Ann)7.75%20.06%
10Y Return (Ann)9.38%8.01%
Sharpe Ratio0.271.35
Daily Std Dev18.05%20.82%
Max Drawdown-96.05%-61.69%
Current Drawdown-23.52%-10.48%

Fundamentals


LHCAH
Market Cap$16.73B$25.10B
EPS$4.62$2.52
PE Ratio42.9440.96
PEG Ratio0.480.31
Revenue (TTM)$12.30B$216.15B
Gross Profit (TTM)$4.39B$6.55B
EBITDA (TTM)$1.62B$2.73B

Correlation

-0.50.00.51.00.3

The correlation between LH and CAH is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

LH vs. CAH - Performance Comparison

In the year-to-date period, LH achieves a -11.11% return, which is significantly lower than CAH's 2.68% return. Over the past 10 years, LH has outperformed CAH with an annualized return of 9.38%, while CAH has yielded a comparatively lower 8.01% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5,000.00%10,000.00%15,000.00%20,000.00%NovemberDecember2024FebruaryMarchApril
1,081.87%
20,231.49%
LH
CAH

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Laboratory Corporation of America Holdings

Cardinal Health, Inc.

Risk-Adjusted Performance

LH vs. CAH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LH
Sharpe ratio
The chart of Sharpe ratio for LH, currently valued at 0.27, compared to the broader market-2.00-1.000.001.002.003.000.27
Sortino ratio
The chart of Sortino ratio for LH, currently valued at 0.50, compared to the broader market-4.00-2.000.002.004.006.000.50
Omega ratio
The chart of Omega ratio for LH, currently valued at 1.06, compared to the broader market0.501.001.501.06
Calmar ratio
The chart of Calmar ratio for LH, currently valued at 0.15, compared to the broader market0.002.004.006.000.15
Martin ratio
The chart of Martin ratio for LH, currently valued at 0.78, compared to the broader market-10.000.0010.0020.0030.000.78
CAH
Sharpe ratio
The chart of Sharpe ratio for CAH, currently valued at 1.35, compared to the broader market-2.00-1.000.001.002.003.001.35
Sortino ratio
The chart of Sortino ratio for CAH, currently valued at 1.88, compared to the broader market-4.00-2.000.002.004.006.001.88
Omega ratio
The chart of Omega ratio for CAH, currently valued at 1.26, compared to the broader market0.501.001.501.26
Calmar ratio
The chart of Calmar ratio for CAH, currently valued at 2.64, compared to the broader market0.002.004.006.002.64
Martin ratio
The chart of Martin ratio for CAH, currently valued at 6.61, compared to the broader market-10.000.0010.0020.0030.006.61

LH vs. CAH - Sharpe Ratio Comparison

The current LH Sharpe Ratio is 0.27, which is lower than the CAH Sharpe Ratio of 1.35. The chart below compares the 12-month rolling Sharpe Ratio of LH and CAH.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2024FebruaryMarchApril
0.27
1.35
LH
CAH

Dividends

LH vs. CAH - Dividend Comparison

LH's dividend yield for the trailing twelve months is around 1.38%, less than CAH's 1.94% yield.


TTM20232022202120202019201820172016201520142013
LH
Laboratory Corporation of America Holdings
1.38%1.18%0.92%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CAH
Cardinal Health, Inc.
1.94%1.98%2.57%3.80%3.62%3.80%4.24%3.00%2.41%1.68%1.65%1.77%

Drawdowns

LH vs. CAH - Drawdown Comparison

The maximum LH drawdown since its inception was -96.05%, which is greater than CAH's maximum drawdown of -61.69%. Use the drawdown chart below to compare losses from any high point for LH and CAH. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-23.52%
-10.48%
LH
CAH

Volatility

LH vs. CAH - Volatility Comparison

Laboratory Corporation of America Holdings (LH) has a higher volatility of 7.03% compared to Cardinal Health, Inc. (CAH) at 6.31%. This indicates that LH's price experiences larger fluctuations and is considered to be riskier than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%5.00%6.00%7.00%8.00%NovemberDecember2024FebruaryMarchApril
7.03%
6.31%
LH
CAH

Financials

LH vs. CAH - Financials Comparison

This section allows you to compare key financial metrics between Laboratory Corporation of America Holdings and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items